Published by Global Banking & Finance Review®
Posted on July 10, 2025
2 min readLast updated: January 23, 2026
Add as preferred source on GoogleUrsula von der Leyen survived a no-confidence vote in the EU Parliament, overcoming far-right opposition and defending her pandemic management.
BRUSSELS (Reuters) -European Commission President Ursula von der Leyen survived a no-confidence vote in European Parliament on Thursday, tabled by mainly far-right lawmakers who said she and her team undermined trust in the EU through unlawful actions.
As expected, the motion failed to get the two-thirds majority it needed to pass.
Romanian nationalist Gheorghe Piperea, the lead sponsor of the motion, had criticised among other things the Commission's refusal to disclose text messages between von der Leyen and the chief executive of Pfizer during the COVD-19 pandemic.
"The decision-making has become opaque and discretionary, and raises fears of abuse and corruption. The cost of obsessive bureaucracy of the European Union such as (tackling) climate change has been a huge one," Piperea told the parliament on Monday.
During the debate on her leadership, von der Leyen defended her record in parliament, rejecting criticism on her management of the pandemic and asserting that her approach ensured equal vaccine access across the EU.
Although the censure motion had little chance of success, it was a political headache for von der Leyen as her Commission negotiates with U.S. President Donald Trump's administration to prevent steep U.S. tariffs on EU goods.
It was the first time since 2014 that a Commission president has faced such a motion. Then president Jean-Claude Juncker also survived the vote.
(Reporting by Charlotte Van Campenhout, Editing by Philip Blenkinsop)
Ursula von der Leyen survived the no-confidence vote in the European Parliament, as the motion failed to achieve the required two-thirds majority.
The motion was primarily sponsored by Romanian nationalist Gheorghe Piperea, who criticized the Commission's transparency and decision-making.
Critics accused her of opaque decision-making and raised concerns about potential abuse and corruption, particularly regarding the EU's bureaucratic processes.
During the debate, von der Leyen defended her record by asserting that her management of the pandemic ensured equal access to vaccines.
This was the first time since 2014 that a Commission president faced such a motion; the previous president, Jean-Claude Juncker, also survived.
Explore more articles in the Headlines category
